Cite
MLA Citation
Peter Bossuyt et al.. “S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies.” American journal of gastroenterology, vol. 116, n.d., pp. S357–S358. http://access.bl.uk/ark:/81055/vdc_100144523636.0x000036